Literature DB >> 24978888

Minocycline and doxycycline, but not tetracycline, mitigate liver and kidney injury after hemorrhagic shock/resuscitation.

Andaleb Kholmukhamedov1, Christoph Czerny, Jiangting Hu, Justin Schwartz, Zhi Zhong, John J Lemasters.   

Abstract

BACKGROUND: Despite recovery of hemodynamics by fluid resuscitation after hemorrhage, development of the systemic inflammatory response and multiple organ dysfunction syndromes can nonetheless lead to death. Minocycline and doxycycline are tetracycline derivatives that are protective in models of hypoxic, ischemic, and oxidative stress. Our aim was to determine whether minocycline and doxycycline protect liver and kidney and improve survival in a mouse model of hemorrhagic shock and resuscitation.
METHODS: Mice were hemorrhaged to 30 mmHg for 3 h and then resuscitated with shed blood followed by half the shed volume of lactated Ringer's solution containing tetracycline (10 mg/kg), minocycline (10 mg/kg), doxycycline (5 mg/kg), or vehicle. For pretreatment plus posttreatment, drugs were administered intraperitoneally prior to hemorrhage followed by second equal dose in Ringer's solution after blood resuscitation. Blood and tissue were harvested after 6 h.
RESULTS: Serum alanine aminotransferase (ALT) increased to 1,988 and 1,878 U/L after posttreatment with vehicle and tetracycline, respectively, whereas minocycline and doxycycline posttreatment decreased ALT to 857 and 863 U/L. Pretreatment plus posttreatment with minocycline and doxycycline also decreased ALT to 849 and 834 U/L. After vehicle, blood creatinine increased to 134 µM, which minocycline and doxycycline posttreatment decreased to 59 and 56 µM. Minocycline and doxycycline pretreatment plus posttreatment decreased creatinine similarly. Minocycline and doxycycline also decreased necrosis and apoptosis in liver and apoptosis in both liver and kidney, the latter assessed by TUNEL (terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling) and caspase 3 activation. Lastly after 4.5 h of hemorrhage followed by resuscitation, minocycline and doxycycline (but not tetracycline) posttreatment improved 1-week survival from 38% (vehicle) to 69% and 67%, respectively.
CONCLUSION: Minocycline and doxycycline were similarly protective when given before as after blood resuscitation and might therefore have clinical efficacy to mitigate liver and kidney injury after resuscitated hemorrhage.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24978888      PMCID: PMC4134396          DOI: 10.1097/SHK.0000000000000213

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  43 in total

1.  Up-regulation of MMP-2 and MMP-9 leads to degradation of type IV collagen during skeletal muscle reperfusion injury; protection by the MMP inhibitor, doxycycline.

Authors:  D M Roach; R A Fitridge; P E Laws; S H Millard; A Varelias; P A Cowled
Journal:  Eur J Vasc Endovasc Surg       Date:  2002-03       Impact factor: 7.069

2.  Hypoxia of endothelial cells leads to MMP-2-dependent survival and death.

Authors:  Yaara Ben-Yosef; Ariel Miller; Sarah Shapiro; Nitza Lahat
Journal:  Am J Physiol Cell Physiol       Date:  2005-11       Impact factor: 4.249

3.  Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice.

Authors:  Shan Zhu; Irina G Stavrovskaya; Martin Drozda; Betty Y S Kim; Victor Ona; Mingwei Li; Satinder Sarang; Allen S Liu; Dean M Hartley; Du Chu Wu; Steven Gullans; Robert J Ferrante; Serge Przedborski; Bruce S Kristal; Robert M Friedlander
Journal:  Nature       Date:  2002-05-02       Impact factor: 49.962

Review 4.  Matrix metalloproteinase inhibitor properties of tetracyclines: therapeutic potential in cardiovascular diseases.

Authors:  Michele M Castro; Arulmozhi D Kandasamy; Nermeen Youssef; Richard Schulz
Journal:  Pharmacol Res       Date:  2011-05-31       Impact factor: 7.658

5.  Doxycycline inhibits MMPs via modulation of plasminogen activators in focal cerebral ischemia.

Authors:  Dorothe Burggraf; Andreas Trinkl; Martin Dichgans; Gerhard F Hamann
Journal:  Neurobiol Dis       Date:  2006-12-12       Impact factor: 5.996

6.  Lipopolysaccharide-binding protein modulates hepatic damage and the inflammatory response after hemorrhagic shock and resuscitation.

Authors:  Mark Lehnert; Tetsuya Uehara; Blair U Bradford; Henrik Lind; Zhi Zhong; David A Brenner; Ingo Marzi; John J Lemasters
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-04-13       Impact factor: 4.052

7.  Minocycline up-regulates Bcl-2 and protects against cell death in mitochondria.

Authors:  Jinzhao Wang; Qingqing Wei; Cong-Yi Wang; William D Hill; David C Hess; Zheng Dong
Journal:  J Biol Chem       Date:  2004-03-05       Impact factor: 5.157

8.  Recovery of hepatocellular ATP and "pericentral apoptosis" after hemorrhage and resuscitation.

Authors:  Markus Paxian; Inge Bauer; Hauke Rensing; Hartmut Jaeschke; Angelika E M Mautes; Stefan A Kolb; Beate Wolf; Andre Stockhausen; Silke Jeblick; Michael Bauer
Journal:  FASEB J       Date:  2003-06       Impact factor: 5.191

9.  Translocation of iron from lysosomes to mitochondria during ischemia predisposes to injury after reperfusion in rat hepatocytes.

Authors:  Xun Zhang; John J Lemasters
Journal:  Free Radic Biol Med       Date:  2013-05-09       Impact factor: 7.376

10.  C-Jun N-Terminal Kinase 2 Promotes Liver Injury via the Mitochondrial Permeability Transition after Hemorrhage and Resuscitation.

Authors:  Christoph Czerny; Tom P Theruvath; Eduardo N Maldonado; Mark Lehnert; Ingo Marzi; Zhi Zhong; John J Lemasters
Journal:  HPB Surg       Date:  2012-06-27
View more
  12 in total

Review 1.  Renoprotective approaches and strategies in acute kidney injury.

Authors:  Yuan Yang; Meifang Song; Yu Liu; Hong Liu; Lin Sun; Youming Peng; Fuyou Liu; Manjeri A Venkatachalam; Zheng Dong
Journal:  Pharmacol Ther       Date:  2016-04-22       Impact factor: 12.310

2.  Suppression of iron mobilization from lysosomes to mitochondria attenuates liver injury after acetaminophen overdose in vivo in mice: Protection by minocycline.

Authors:  Jiangting Hu; John J Lemasters
Journal:  Toxicol Appl Pharmacol       Date:  2020-02-25       Impact factor: 4.219

Review 3.  Similarities and differences between doxycycline and minocycline: clinical and antimicrobial stewardship considerations.

Authors:  B A Cunha; J Baron; C B Cunha
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-08-17       Impact factor: 3.267

Review 4.  Phospholipids in mitochondrial dysfunction during hemorrhagic shock.

Authors:  Galina F Leskova
Journal:  J Bioenerg Biomembr       Date:  2016-12-20       Impact factor: 2.945

5.  Minocycline attenuates colistin-induced neurotoxicity via suppression of apoptosis, mitochondrial dysfunction and oxidative stress.

Authors:  Chongshan Dai; Giuseppe D Ciccotosto; Roberto Cappai; Yang Wang; Shusheng Tang; Xilong Xiao; Tony Velkov
Journal:  J Antimicrob Chemother       Date:  2017-06-01       Impact factor: 5.790

Review 6.  Pathophysiology of Hemorrhage as It Relates to the Warfighter.

Authors:  Carmen Hinojosa-Laborde; Ian L Hudson; Evan Ross; Lusha Xiang; Kathy L Ryan
Journal:  Physiology (Bethesda)       Date:  2022-01-10

7.  Potential adverse effects of ciprofloxacin and tetracycline on ARPE-19 cell lines.

Authors:  Nasim Salimiaghdam; Lata Singh; Kevin Schneider; Angele Nalbandian; Marilyn Chwa; Shari R Atilano; Andrea Bao; M Cristina Kenney
Journal:  BMJ Open Ophthalmol       Date:  2020-07-21

8.  Protective outcomes of low-dose doxycycline on renal function of Wistar rats subjected to acute ischemia/reperfusion injury.

Authors:  Aline L Cortes; Sabrina R Gonsalez; Lilimar S Rioja; Simone S C Oliveira; André L S Santos; Minolfa C Prieto; Paulo A Melo; Lucienne S Lara
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-10-05       Impact factor: 5.187

9.  Apelin protect against multiple organ injury following hemorrhagic shock and decrease the inflammatory response.

Authors:  Mona Soliman; Maha Arafah
Journal:  Int J Appl Basic Med Res       Date:  2015 Sep-Dec

10.  OSM potentiates preintravasation events, increases CTC counts, and promotes breast cancer metastasis to the lung.

Authors:  Ken Tawara; Celeste Bolin; Jordan Koncinsky; Sujatha Kadaba; Hunter Covert; Caleb Sutherland; Laura Bond; Joseph Kronz; Joel R Garbow; Cheryl L Jorcyk
Journal:  Breast Cancer Res       Date:  2018-06-14       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.